Central Europe - Biotech Research

France's Sanofi-Aventis SA must sell off medicines in eastern Europe to win EU antitrust approval to buy a Czech generic drug maker, the European Commission said Wednesday. The French pharmaceutical company is paying euro1.8 billion ($2.3 billion) for Zentiva to broaden its ...